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Abstract
Background: Although the toxicological impacts of the xenoestrogen bisphenol-A (BPA) have been studied
extensively, but the mechanism of action is poorly understood. Eventually, no standard method exists for evaluating
the possible health hazards of BPA exposure. Considering mice spermatozoa as a potential in vitro model, we
investigated the effects of BPA exposure (0.0001, 0.01, 1, and 100 μM for 6 h) on spermatozoa and the related
mechanisms of action. The same doses were also employed to evaluate protein profiles of spermatozoa as a means
to monitor their functional affiliation to diseases.
Results: Our results demonstrated that high concentrations of BPA negatively affect sperm motility, viability,
mitochondrial functions, and intracellular ATP levels by activating the mitogen-activated protein kinase,
phosphatidylinositol 3-kinase, and protein kinase-A pathways. Moreover, short-term exposure of spermatozoa to
high concentrations of BPA induced differential expressions of 24 proteins. These effects appeared to be caused by
protein degradation and phosphorylation in spermatozoa. Proteins differentially expressed in spermatozoa from
BPA treatment groups are putatively involved in the pathogenesis of several diseases, mainly cancer, carcinoma,
neoplasm, and infertility.
Conclusions: Based on these results, we propose that BPA adversely affects sperm function by the activation of
several kinase pathways in spermatozoa. In addition, BPA-induced changes in the sperm proteome might be partly
responsible for the observed effects in spermatozoa, subsequently involve in the pathogenesis of many diseases.
Therefore, we anticipated that current strategy might broadly consider for the health hazards assessment of other
toxicological agents.
Keywords: Bisphenol-A, Health hazards, In-vitro, Spermatozoa, Proteomics, Bioinformatics databases, Diseases,
Signaling pathways
Background
Bisphenol-A (BPA) is an estrogenic endocrine disruptor
and is produced annually in large quantities for the pro-
duction of polycarbonate plastics and epoxy resins. Be-
cause of hormone-like properties, concerns have been
raised about the sustainability of BPA in consumer prod-
ucts. The Centers for Disease Control and Prevention
has identified high levels of urinary BPA in >90 % of the
U.S. population [1]. BPA is associated with impaired re-
productive functions as well as other diseases, such as
cancer, diabetes, obesity, cardiovascular disease, thyroid
dysfunction, developmental disorders, and miscarriages
[2]. Several in vivo studies have reported that BPA-
exposed males are prone to reproductive developmental
disorders [3, 4] and that the spermatozoa of exposed
males are incapable of proper sperm-oocyte binding,
thereby affecting embryonic growth [5]. Recently we
have reported that BPA-induced modifications of fertility-
related proteins in spermatozoa are associated with in-
creased reproductive health risk [6].
Genomic and non-genomic pathways are two pro-
posed mechanisms by which xenoestrogens exert
their hormone-like action. In the genomic pathway,
xenoestrogens trigger estrogen receptors (ERs, nu-
clear and cytoplasmic) and lead to the transcription
of target genes, thereby affecting cell function [7]. In
the non-genomic pathway, G protein-coupled recep-
tors (GPCRs) together with membrane-bound ERs
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(non-genomic) cause rapid estrogenic signaling through
activation of mitogen-activated protein kinase (MAPK)
and phosphatidylinositol 3-kinase (PI3K), changes in
cAMP/protein kinase-C (PKC), and fluctuation of intra-
cellular calcium [8]. Consistently, BPA also has been re-
ported to exert its effects via activation of MAPK and
PI3K in human ovarian cancer cells [9, 10]. As demon-
strated, mature spermatozoa contain functional GPCRs
[11] and non-genomic ERs [12], therefore, provide a
valid model to investigate the molecular mechanism of
BPA action [6, 13, 14].
Recent advances in proteomic research have offered a
new vista for developing proteomic biomarkers of chem-
ical exposure, with the aim of evaluating hostile health
effects [15]. In particular, two-dimensional gel electro-
phoresis (2-DE) coupled with mass spectrometry (MS)
has been used effectively in several toxicology studies
and in high-throughput industrial applications. A direct
comparison of protein expression levels from control
versus altered conditions reveals a set of biomarkers rep-
resentative of the altered state. Since spermatozoa have
no functional protein synthesizing machinery, therefore
provide a valid model for proteomic analysis [16–18].
Consequently, several laboratories have applied this
technique to develop diagnostic biomarkers of spermato-
zoa in different functional states [16, 17]. However, to
date, efforts to establish protein expression profiles indi-
cative of xenoestrogen (BPA) exposure in spermatozoa
have not been attempted. Therefore, the objectives of
the current study were: 1) to determine whether differ-
ent concentrations of BPA could affect sperm functions,
and if so, to investigate the mechanisms linked with
these observed effects and 2) to identify the differentially
expressed proteins of exposure as a manner to screen
their functional affiliation to diseases.
Results
The effect of BPA on motility, viability, and intracellular
lactate dehydrogenase (LDH) levels in spermatozoa
The percentage of motile spermatozoa decreased signifi-
cantly in the presence of 100 μM of BPA (p < 0.05)
(Fig. 1a). However, the sperm viability was affected sig-
nificantly by exposure to both 1 and 100 μM BPA (p <
0.05) (Fig. 1b). In contrast, a non-significant increase of
Fig. 1 Effect of BPA on motility, viability, lactate dehydrogenase (LDH), mitochondrial activity, and intracellular ATP ([ATP]i) levels. (a) Differences in
motility in BPA-treated and control spermatozoa. (b) Differences in number of viable spermatozoa between the control and BPA treatment.
(c) Differences in LDH levels in control and BPA-treated spermatozoa. (d) Representative flow cytometry images of mitochondrial activity in control
and BPA-treated spermatozoa. (e) The bar represents the difference in mitochondrial activity detected by flow cytometry in control and
BPA-treated spermatozoa. (f) Differences in [ATP]i levels between control and BPA-treated spermatozoa. Data are presented as mean ± SEM
(4 replicates). Values with different superscript characters (A,B,a,b) indicate significant differences between the control and treatment groups as
determined by one-way ANOVA (p < 0.05)
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intracellular LDH levels was noted in all concentrations
of BPA tested (Fig. 1c).
The effect of BPA on mitochondrial activity and
intracellular ATP ([ATP]i) levels in spermatozoa
Mitochondrial respiration produces ATP, which is re-
quired to maintain sperm motility and other biochemical
modifications required for fertilization [19]. Current study
showed that a high concentration of BPA (100 μM) sig-
nificantly altered the mitochondrial activity of sperm-
atozoa (p < 0.05) (Fig. 1d and e). To validate whether
these alterations of mitochondrial activity were corre-
lated with overall [ATP]i production, we measured the
[ATP]i levels in spermatozoa. Our results revealed that
high concentrations of BPA were also able to significantly
reduce [ATP]i levels compared with those of other tested
concentrations and the control (p < 0.05) (Fig. 1f).
BPA stimulates MAPK, PI3K, and PKA pathways in
spermatozoa
As reported previously [9, 10], BPA activates the MAPK
and PI3K signaling pathways in ovarian cancer cells. To
evaluate this possibility in spermatozoa, activation of
MAPK(p38) and PI3K(p85) were evaluated using west-
ern blot analyses. Our results showed that BPA induced
a dose-dependent increase in both phospho-MAPK
(p38) and phospho-PI3K (p85) (Fig. 2a–d). Further, it
has been demonstrated that the activation of the
Fig. 2 Effect of BPA on MAPK (p38), PI3K (p85), and PKA signalings pathways in spermatozoa. (a) The bar represents the densities of phospho-
MAPK (p38) in BPA-treated and control spermatozoa. (b) Representative western blot image of phospho-MAPK (p38) probed with specific
antibody. (c) Densities of phospho-PI3K (p85) in BPA-treated and control spermatozoa. (d) Representative western blot image of phospho-PI3K
(p85) probed with specific antibody. (e) Densities of PKA substrate species in BPA-treated and control spermatozoa. (f) Phospho-PKA substrates
were probed with an anti-phospho-PKA antibody. Lane 1: control; lane 2: 0.0001 μM BPA; lane 3: 0.01 μM BPA; lane 4: 1 μM BPA; and lane 5:
100 μM BPA. Data are presented as mean ± SEM (3 replicates). Values with different superscript characters (A,B,a,b,α,β) indicate significant differences
between the control and treatment groups as determined by one-way ANOVA (p < 0.05)
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MAPK/PI3K signaling pathways regulates PKA activity
to maintain complex cross-talk between these path-
ways [20, 21]. Therefore, to further discriminate the
PKA activity in spermatozoa due to exposure of BPA,
PKA levels were also measured. Significant increases
in the levels of three PKA substrates (~100, 50, and
26 kDa) were observed in the presence of 100 μM of
BPA (p < 0.05) (Fig. 2e and f ).
Identification and quantification of proteins differentially
expressed in control and BPA-exposed spermatozoa
To learn pathophysiological importance of BPA exposure,
we applied a proteomic approach (2-DE coupled with MS)
for identification of differentially expressed proteins in
spermatozoa. On average, 399 spots were consistently de-
tected in all gels, 250 of which shared almost similar ex-
pression patterns across treatments. Fifty spots showed a
dose-dependent expression profile, but significant (P <
0.05) changes were noticed in 29 spots. In our assessment
of the dose-dependent expression profiles, we avoided
nine spots that demonstrated non-linear differences in ex-
pression between treated and control groups. Finally, we
identified 24 spots by electrospray ionization tandem mass
spectrometry (ESI-MS/MS). The identified proteins spots
and their normalized spot values in the control and BPA-
treated spermatozoa are shown in Fig. 3 and Table 1, re-
spectively (the detailed information regarding peptide se-
quence, matches peptides, and used searching engine of
identified proteins were provided in Additional file 1:
Table S1). Our results showed that 24 proteins (16 down-
and 9 up-regulated) were differentially expressed between
BPA-treated (100 μM) and control spermatozoa (Table 1).
The number of differentially expressed proteins in control
vs 0.01 μM and control vs 1 μM were 3 (2 down- and 1
up-regulated) and 7 (4 down- and 3 up-regulated), re-
spectively (Table 1). Additionally, using Gene Ontology
annotation in bioinformatics databases (UniProt-GOA
and Human Sperm Proteome), the identified proteins
were characterized according to their biological function
as listed in Table 1.
Functional analysis and signaling pathways of
differentially expressed proteins
Pathway Studio program was used to identify signaling
pathways regulated by the differentially expressed proteins.
Our results showed a significant association between five
canonical signaling pathways and some of the differentially
expressed proteins (p < 0.05) (Table 2). We also identified
and schematized the clinical significance of these proteins
using a MedScan Reader (v5.0) search and Pathway Stu-
dio, respectively. The disease processes regulated by the
differentially expressed proteins are compiled in Fig. 4a.
Western blot analysis of six representative proteins and
phospho-tyrosine proteins
To validate the 2-DE results, six differentially expressed pro-
teins, such as glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), cytochrome b-c1 complex (UQCRFS1), peroxi
redoxin-5 (PRDX5), glutathione peroxidase (GPX4), actin,
cytoplasmic 1 (ACTB), and glutathione S-transferase
(GSTM5) were further verified by western blot analyses
using their commercially available antibodies. The west-
ern blot results confirmed the differentially expressed
protein levels visualized in 2-DE (Additional file 2: Figure
S1). Western blot also was applied to investigate the
phospho-tyrosine levels (PY20) in both the treated and
control spermatozoa. Significant increases in the levels of
two tyrosine-phosphorylated species (~100 and ~24 kDa)
were detected in BPA-treated (1 and 100 μM) sperm-
atozoa compared with the control (p < 0.05) (Additional
file 2: Figure S2).
Discussion
BPA has been regarded as a ubiquitous environmental
chemical to which we are exposed in everyday life.
Considering the toxicological importance of BPA, here
we attempted to investigate whether several concentra-
tions of BPA would affect sperm functions and to inves-
tigate the molecular mechanisms. Additionally, BPA
was employed to separate differentially expressed pro-
teins in spermatozoa as a manner to monitor their
functional affiliation to several disease processes.
Our results showed that higher concentrations of BPA
significantly decreased sperm motility (Fig. 1a) and via-
bility (Fig. 1b), even the doses that were potentially non-
toxic (Fig. 1c). Several earlier studies also demonstrated
the similar action of BPA on sperm motility in rats and
mice [6, 22, 23]. It has been reported that mitochondrial
respiration mainly provides ATP to support sperm mo-
tility [19]. To evaluate this possibility, the effect of
BPA on mitochondrial activity and [ATP]i also were
evaluated. Consistent with the motility and viability
data, 100 μM BPA altered the mitochondrial activity
significantly (Fig. 1d and e) and decreased the [ATP]I
(Fig. 1f ). Collectively, our findings support that BPA
(~100 μM) alters the mitochondrial activity and de-
creases [ATP]i and, thus, could affect sperm functions
(motility/viability).
BPA has been demonstrated to activate the MAPK
and PI3K signaling pathways in cancer cells [9, 10, 24].
It has been demonstrated that p38 (MAPK) and p85
(PI3K) proteins are rapidly tyrosine-phosphorylated in
response to extracellular stimuli and trigger subsequent
activation of the kinase systems [25, 26]. We have shown
that the addition of BPA to spermatozoa leads to a signifi-
cant dose-dependent induction of the phospho-MAPK
(p38) and phospho-PI3K (p85), thereby activating both
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kinase pathways (Fig. 2a–d). Activation of MAPK [27]
and PI3K [28] also has been reported in ejaculated bo-
vine spermatozoa due to exposure of extracellular stim-
uli. On the other hand, PKA has been shown to be
essential for the regulation of major signaling pathways
in spermatozoa [6, 29], as well as cross-talk between
MAPK and PI3K signaling [20, 21]. Further, the
activation of the PKA pathway by structurally diverse
estrogenic compounds, including BPA, also has been
reported [24]. Therefore, we performed western blot
analysis for PKA activity (Fig. 2e and f ), in treated
and control spermatozoa. Consistent with previous
finding in other cells, collectively our results support
that BPA activates the MAPK, PI3K, and PKA
Fig. 3 Representative silver nitrate stained image of 2-DE protein spot. (a) Protein spots of control spermatozoa. (b) Protein spots of
0.0001 μM of BPA-treated spermatozoa. (c) Protein spots of 0.01 μM of BPA-treated spermatozoa. (d) Protein spots from 1 μM of BPA treated-
spermatozoa. e Protein spots of 100 μM BPA-treated spermatozoa
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signaling in spermatozoa and ultimately affects the
cell functions.
A recent technological advance in proteomics is that
researchers have successfully developed diagnostic bio-
markers of several diseases [15]. Nevertheless, complete
proteomic biomarkers indicative of xenoestrogen
exposure (eg BPA) in spermatozoa still remain un-
known. Therefore, we have performed 2-DE coupled
with MS to identify unique protein expression profiles
in BPA-treated spermatozoa to predict the patho-
physiological consequences of exposure. Our results
showed that 24 proteins (16 down- and 9 up-regulated)
Table 1 Proteins with a significantly lower or higher expression in treatment and control groups
Symbol Protein description gi no. MASCOT
score*
Relative intensitya (normalized)
Control 0.0001 0.01 1 100
Energy metabolism (46 %)
ATP5H ATP synthase subunit d, mitochondrial gi|21313679 58 1A 0.99 ± 0.15A 0.93 ± 0.12A 0.63 ± 0.01A,B 0.36 ± 0.12B
ATP5O ATP synthase subunit O, mitochondrial gi|20070412 69 1A 0.97 ± 0.19A 0.68 ± 0.14A,B 0.62 ± 0.08A,B 0.44 ± 0.07B
HADHA Trifunctional enzyme subunit alpha,
mitochondrial
gi|33859811 66 1A 0.71 ± 0.01A,B 0.41 ± 0.03B,C 0.40 ± 0.04B,C 0.31 ± 0.10C
COX6A1 Cytochrome c oxidase subunit 6A1,
mitochondrial
gi|1352173 49 1A 0.68 ± 0.19A,B 0.28 ± 0.07B,C 0.23 ± 0.06B,C 0.17 ± 0.01C
PGAM2 Phosphoglycerate mutase 2 gi|9256624 53 1A 0.99 ± 0.13A 0.76 ± 0.13A,B 0.72 ± 0.08A,B 0.34 ± 0.07B
OXCT2A Succinyl-CoA:3-ketoacid coenzyme A
transferase 2A, mitochondrial
gi|81881929 36 1A 0.71 ± 0.16A,B 0.67 ± 0.07A,B 0.65 ± 0.04A,B 0.43 ± 0.09B
ISOC2A Isochorismatase domain-containing
protein 2A, mitochondrial
gi|197333728 73 1A 0.83 ± 0.19A,B 0.79 ± 0.08A,B 0.75 ± 0.10A,B 0.34 ± 0.12B
GAPDH Glyceraldehyde-3-phosphate
dehydrogenase, testis-specific
gi|2494630 37 1A 1.09 ± 0.14A 1.11 ± 0.25A,B 1.12 ± 0.31A,B 2.17 ± 0.28B
AK2 Adenylate kinase 2, mitochondrial isoform gi|34328230 70 1A 1.13 ± 0.18 A,B 1.19 ± 0.27A,B 1.37 ± 0.11A,B 2.05 ± 0.14B
SDHB Succinate dehydrogenase Ip subunit gi|34328286 63 1A 2.59 ± 0.66A,B 3.02 ± 0.29A,B 3.32 ± 0.56B 3.27 ± 0.38B
UQCRFS1 Cytochrome b-c1 complex subunit
Rieske, mitochondrial
gi|13385168 62 1A 1.56 ± 0.17A,B 1.62 ± 0.40A,B 1.72 ± 0.32A,B 2.16 ± 0.01B
Cytoskeletal/structural proteins (25 %)
ROPN1 Ropporin-1 gi|74227586 202 1A 0.88 ± 0.12A 0.78 ± 0.10A,B 0.71 ± 0.10A,B 0.49 ± 0.01B
ACTB Actin, cytoplasmic 1 gi|6671509 51 1A 0.93 ± 0.17A 0.92 ± 0.16A 0.49 ± 0.04B 0.47 ± 0.04B
FABP9 Fatty acid-binding protein 9 gi|166897974 68 1A 0.94 ± 0.05A 0.86 ± 0.13A 0.68 ± 0.03A,B 0.47 ± 0.07B
ODF2 Outer dense fiber protein 2 gi|2290719 57 1A 0.68 ± 0.14A,B 0.62 ± 0.19A,B 0.59 ± 0.16A,B 0.13 ± 0.01B
PMP20 Peroxisomal membrane protein 20 gi|6746357 79 1A 1.06 ± 0.05A 1.10 ± 0.06A,B 1.17 ± 0.22A,B 2.11 ± 0.01B
ASRGL1 Isoaspartyl peptidase/L-asparaginase gi|81875980 52 1A 1.38 ± 0.12A,B 2.09 ± 0.87A,B 2.79 ± 0.42A,B 3.23 ± 0.36B
Fertility Related Proteins (17 %)
PHB Prohibitin gi|6679299 68 1A 0.91 ± 0.12A 0.81 ± 0.20A,B 0.75 ± 0.12A,B 0.43 ± 0.05B
PPP1CA Serine/threonine-protein phosphatase
PP1-alpha catalytic subunit
gi|49065812 50 1A 0.94 ± 0.16A 0.60 ± 0.20A,B 0.47 ± 0.07A,B 0.36 ± 0.05B
DNAL1 Dynein light chain 1, axonemal gi|164607162 67 1A 0.74 ± 0.01A,B 0.65 ± 0.14 A,B 0.64 ± 0.23A,B 0.49 ± 0.13B
SPA17 Sperm surface protein Sp17 gi|6755614 58 1A 1.11 ± 0.21A 1.39 ± 0.81A 1.59 ± 0.05A,B 2.08 ± 0.17B
Stress response proteins/ROS metabolism (12 %)
GSTM5 Glutathione S-transferase Mu 5 gi|6754086 70 1A 0.92 ± 0.26A,B 0.67 ± 0.08A,B 0.48 ± 0.09B 0.32 ± 0.08B
GPX4 Glutathione peroxidase gi|3075477 65 1A 1.71 ± 0.08A,B 1.87 ± 0.19B 2.24 ± 0.24B 2.25 ± 0.15B
PRDX5 Peroxiredoxin-5, mitochondrial gi|6755114 73 1A 1.28 ± 0.17A,B 1.30 ± 0.15A,B 2.02 ± 0.11B 2.35 ± 0.09B
*MASCOT score is −10 log (P), where P is the probability that the observed match is a random event. Individual scores > 30 indicate identity or extensive
homology (p < 0.05). aRelative spots intensity in control and BPA-treated (μM) spermatozoa. Data are presented as mean ± SEM (3 replicates). Values with different
superscript characters (A,B,C) indicate significant differences between the control and treatment groups as determined by one-way ANOVA (P < 0.05)
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were dose dependently (p < 0.05) expressed between
BPA-treated and control spermatozoa (Table 1). Pro-
tein degradation (down-regulation) in spermatozoa due
to environmental factors is well studied [6, 16, 17];
however, the manner in which protein levels are in-
creased in vitro need to be investigated. Mature sperm-
atozoa are silent in both transcription and translation
or are poorly capable of translation [6]. Therefore, pro-
tein up-regulation could be achieved by posttransla-
tional modification, such as tyrosine phosphorylation
[6, 16, 17, 30]. A similar increase in protein tyrosine
phosphorylation was also found in spermatozoa due to
BPA exposure (Additional file 2: Figure S2). Taken to-
gether with several recent studies [6, 16, 17, 30], our
results suggest that exposure to BPA induces protein
degradation and phosphorylation in spermatozoa, ul-
timately affecting sperm function.
A total of 11 (46 %) proteins involved in energy me-
tabolism exhibited altered levels in BPA-exposed
(100 μM) spermatozoa compared with those of the
control (Table 1). Proteins warranting attention for be-
ing degraded were mitochondrial ATP synthase subunit
d (ATP5H), mitochondrial ATP synthase subunit O
(ATP5O), mitochondrial trifunctional enzyme subunit
alpha (HADHA), mitochondrial cytochrome c oxidase
subunit 6A1 (COX6A1), phosphoglycerate mutase 2
(PGAM2), mitochondrial succinyl-CoA:3-ketoacid co-
enzyme A transferase 2A (OXCT2A), and mitochon-
drial isochorismatase domain-containing protein 2A
(ISOC2A) (Table 1). Most of the degraded proteins
Fig. 4 Differentially expressed proteins regulated cellular processes/diseases and hypothetical depiction of BPA action. (a) BPA-induced differentially
expressed (p < 0.05) proteins regulated cellular processes and diseases as depicted by Pathway Studio software. Differentially expressed proteins have
been highlighted in yellow background. At least 11 proteins among the 24 differentially expressed proteins were implicated in different disease
processes. (b) Hypothetical depiction showing the effects of BPA in spermatozoa and the possible mechanism of action. BPA may bind to
membrane receptors on spermatozoa that induce rapid phosphorylation of MAPK (p38), PI3K (p85), PKA substrates and subsequent activation
of the kinase systems. Simultaneously, BPA induced the phosphorylation of tyrosine residue (Try-P) of sperm proteins. BPA induced changes in
spermatozoa affect the overall protein content of the spermatozoa, ultimately predispose to several pathological outcome
Table 2 Signaling pathways associated with differentially expressed proteins as identified by Pathway Studio program
Signaling Pathways Overlapping Entities P-value
Respiratory chain and oxidative phosphorylation UQCRFS1, SDHB, COX6A1, ATP5O <0.001
Glutathione metabolism GSTM5, GPX4, PRDX5 0.017
Notch Pathway ACTB, PPP1CA, HADHA, PGAM2, ODF1, GAPDH 0.017
EphrinR - > actin signaling ACTB, ODF1 0.030
Adipocytokine Signaling SDHB, HADHA, PGAM2, GAPDH 0.031
BPA-induced differentially expressed proteins were entered into the Pathway Studio program to identify the significantly signaling pathways. The probabilities of
the signaling pathways were determined using the Fisher’s exact test (p < 0.05)
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identified in this group were mitochondrial isoforms,
thus predominantly involved in energy metabolism.
Therefore, down-regulation of these proteins could
affect the overall mitochondrial functions and ATP
production as also demonstrated in current study
(Fig. 1f ). Clinically, the ATP synthase subunit and
HADHA have been shown to be down-regulated in
type 2 diabetes [31] and hepatocellular cancer cells
[32], respectively. Moreover, COX6A1 exerts a protect-
ive role against ROS-induced cell damage; thus, its
down-regulation could lead to abnormal cell functions
[33]. It is important to note that a significant down-
regulation of HADHA and COX6A1 were detected be-
tween the control and 0.01/1 μM BPA exposure
(Table 1), and therefore, these proteins could provide
potential biomarkers of low dose effects. On the other
hand, the up-regulated proteins of energy metabolism
group were GAPDH, mitochondrial isoform of adenyl-
ate kinase 2 (AK2), succinate dehydrogenase Ip subunit
(SDHB), and UQCRFS1 (Table 1). It is unclear, how
sperm motility (Fig. 1a) and ATP (Fig. 1f ) are de-
creased in the condition when energy metabolism pro-
teins are increased. However, the level of expression
may be suboptimal to overcome BPA-mediated toxicity,
and/or the substantial increases may result in atypical
functioning of these proteins.
Six cytoskeletal/structural proteins (25 %) were found
to be significantly altered in 100 μM BPA-treated sperm-
atozoa compared to those in the control cells (Table 1).
The down-regulated proteins were ropporin-1 (ROPN1),
ACTB, fatty acid-binding protein 9 (FABP9), and outer
dense fiber protein 2 (ODF2) (Table 1). The cytoskeletal/
structural proteins are important for cytoplasmic integ-
rity, cell movement, and signal transduction mainten-
ance. Therefore, down-regulation of these proteins could
affect the cellular physiology. Clinically, down-regulation
of these proteins has been found in non-motile, abnor-
mal headed, infertile spermatozoa [18, 34]. Addition-
ally, the functional affiliation of these proteins also has
been reported to prostatic carcinoma and metastatic
melanoma of the testis [35, 36]. In contrast, the up-
regulated proteins were peroxisomal membrane protein
20 (PMP20) and isoaspartyl peptidase/L-asparaginase
(ASRGL1) (Table 1); interestingly, neither of them had
been previously described in spermatozoa. Therefore,
they might be the possible biomarkers of BPA hazard
assessment; however, further study needs to be con-
ducted to strengthen this hypothesis.
Additionally, in fertility-related proteins (17 %), sperm
surface protein Sp17 (SPA17) was increased by BPA ex-
posure (100 μM), whereas prohibitin (PHB), serine/
threonine-protein phosphatase PP1-alpha catalytic sub-
unit (PPP1CA), and axonemal dynein light chain 1
(DNAL1) were decreased (Table 1). SPA17 has been
reported to play a potential role in sperm-egg interac-
tions; however, increased functionality of this protein in-
duced immature acrosome reaction and tumor changes
in cells [37], which might support our current findings.
In contrast, the degraded proteins are reported to play
potential roles in the regulation of sperm motility and
fertilization [38, 39]. Thus, degradation of these proteins
results in spermatozoa with reduced motility and viabil-
ity (Fig. 1a and b). Lastly, among stress response pro-
teins (12 %), GPX4 and PRDX5 were up-regulated, and
GSTM5 was down-regulated by BPA (Table 1). It has
been reported that toxic levels of ROS in mammalian
spermatozoa are strongly associated with male infertility
[29]. Thus, failure of the antioxidant defense system of
spermatozoa to remove excess ROS levels ultimately
compromises normal sperm function and fertilization.
Therefore, the elevated levels of GPX4 and PRDX5 ob-
served in the present study were assumed to offer the
sperm cells a survival advantage (Fig. 1c) in a BPA-
containing microenvironment. In addition, significantly
increased expression of GPX4 was noted with 0.01 μM
BPA treatment compared with control (Table 1), and
thus, GPX4 could represent a brilliant candidate bio-
marker of low-dose exposure.
Our data showed that 13 of 24 differentially expressed
proteins in BPA-treated spermatozoa were signifi-
cantly (p < 0.05) correlated with five canonical path-
ways (Table 2). Since normal functioning of these
pathways regulates cell physiology, manipulation of
pathway entities definitely correlates with pathological
consequences/diseases. Using Pathway Studio pro-
gram, we show that the disease processes regulated by
the altered proteins of these pathways were putatively
involved in cancer, carcinoma, neoplasm, infertility,
and so, (Fig. 4a). However, the Pathway Studio pro-
gram showed the particular proteins regulated path-
ways, cellular processes, and diseases from entries in
the PubMed and other related databases; thus, the
proteins that exhibited a non-significant relationship
with several pathways might also have potential clin-
ical significance.
Conclusions
Here, we describe the in vitro effects of BPA on mouse
spermatozoa and the possible mechanisms of action.
Additionally, we identified 24 differentially expressed
proteins in spermatozoa indicative of BPA exposure and
showed their affiliation with several diseases (Fig. 4b).
These predicted protein markers could be used as po-
tential candidates for developing a novel theranostic
strategy for the management of BPA toxicity. Addition-
ally, we anticipated that the proteomics and informatics
tools used current study might consider for the health
hazard assessment of other toxicological agents.
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However, further studies are required to validate prelim-
inary finding and to better elucidate the possible clinical
applications of these techniques.
Methods
Ethical approval
All procedures with animals were performed in accord-
ance to protocols approved by the Institutional Animal
Care and Use Committee of Chung-Ang University,
Seoul, Republic of Korea.
Media and chemicals
All chemicals and reagents were purchased from Sigma-
Aldrich (St. Louis, MO, USA), unless otherwise stated.
Modified Tyrode’s medium (osmolality 300 ± 20 mOsm/
kg, pH 7.2 ± 0.2) was prepared freshly and used as basic
medium (BM) [6, 29]. The BM was pre-incubated 1 day
prior to the experiment and supplemented with bovine
serum albumin (BSA; 4 mg/mL). BPA was dissolved in
dimethylsulfoxide (DMSO) and added to a final concen-
tration to treat the spermatozoa. The control spermato-
zoa were treated with DMSO only. An estrogenic
positive control was not considered in the present
study because BPA has been reported to act via other
signaling pathways together with ERs; thus, it is not ob-
vious whether BPA and natural estrogens have similar
effects [40, 41].
BPA dose selection
The exposure scheme consisted of four different doses
of BPA: 0.0001, 0.01, 1, and 100 μM. The doses up to
1 μM were comparable to the acceptable human daily
exposure levels [22]. It has been demonstrated that
low dose of BPA (~0.01 μM) advances early embryonic
development, whereas a comparatively higher dose
(~100 μM) decreases the development rate of the em-
bryo [42, 43]. More recently, genotoxic and mitogenic
effects of BPA has been demonstrated at the dose of
0.01–0.1 μM, in mammary cells [44]. Therefore, range
of concentrations (0.001–100 μM) was considered in
current study to clarify in vitro adverse effect levels of
BPA in spermatozoa.
Collection and preparation of spermatozoa and their
exposure to BPA
Spermatozoa were collected from sexually mature ICR
male mice (Nara Biotech, Seoul, Korea) following pub-
lished procedures [6, 29]. Briefly, both cauda epididy-
mides from each mouse were collected and the
associated fat was removed. The epididymides were then
placed in cell culture dishes with BM containing 0.4 %
BSA, and punctured using a sterile needle to release
spermatozoa. The released spermatozoa were incubated
for approximately 10 min with 5 % CO2 in air at 37 °C
to facilitate dispersal. An initial experiment was designed
to determine the potential of BPA to alter a) sperm mo-
tility and b) viability. For this, the spermatozoa were in-
cubated (5 % CO2 in air at 37 °C) with 100 μM BPA for
different periods of time (ranging from 0.5 to 8 h at 30-
min intervals) to investigate the potential shift of both
parameters. Finally, 6 h was identified as the minimum
effective period of BPA exposure. Therefore, the sperm
suspension was incubated for 6 h under the same con-
ditions in BM supplemented with various concentra-
tions of BPA.
Assessment of sperm motility
Sperm motility was evaluated using computer-assisted
sperm analysis (CASA) (SAIS plus version 10.1; Medical
Supply, Seoul, Korea) according to described methods
[6, 29]. The 10× phase contrast objective was used by
the SAIS software to relay and analyze the spermatozoa.
Five fields of each sample were randomly selected to
evaluate the movement of at least 250 sperm.
Hypo-osmotic swelling test (HOST)
To evaluate sperm viability and functional integrity
(membrane), we used the hypo-osmotic swelling test
(HOST) as described previously [45]. The sperm swell-
ing patterns were classified broadly as viable and/or
nonviable according to the WHO 2010 manual and by
using the Microphot-FXA microscope (Nikon).
Detection of LDH
To determine cytotoxicity, the CytoTox 96® assay kit
(Promega, Fitchburg, WI, USA), which is based on the
colorimetric detection of LDH, was used according to
the method described previously [6, 29]. The LDH activ-
ity was measured as the absorbance at 490 nm by using
a luminometer (GEMINI EM, Molecular Devices Cor-
poration) and was calculated using the SoftMax Pro 5
software. Activity is reported as the ratio of the fluores-
cence of BPA-treated samples to that of the control.
Detection of mitochondrial activity
Mitochondrial membrane potential, defined as mitochon-
drial activity, was measured by rhodamine 123 (R123)
staining according to the manufacturer’s directions and
the described method [45]. The samples were analyzed by
flow cytometry (Becton Dickinson, Franklin Lakes, NJ,
USA) with an excitation wavelength of 488 nm and an
emission wavelength of 525 nm. Ten thousand cells in
each sample were considered to obtain R123 signal,
and the signal was analyzed using the CellQuest soft-
ware (Becton Dickinson). Mitochondrial activity was
reported as the fluorescence of the BPA-treated sam-
ples compared with that of the control.
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Detection of [ATP]i levels
[ATP]i was detected using an ATP Bioluminescence Assay
Kit (CLS II; Roche Molecular Biochemicals, Mannheim,
Germany) according to the described method [29]. The lu-
minescence signal was detected using a Microplate Multi-
mode Reader (GloMax®-Multi; Promega, Madison, WI,
USA). The [ATP]i is reported as the ATP (signal) of the
BPA-treated samples compared with that of the control.
Preparation of spermatozoa for proteomic experiments
The BPA-treated and control spermatozoa after 6 h of
incubation were washed twice by centrifugation (100 × g
for 2.5 min) at room temperature (RT), re-suspended in
BM, and allowed to swim-up at 37 °C for an additional
15 min. Swim-up was performed to separate the motile
sperm fraction from immature spermatozoa and somatic
cells [46–48]. The motile sperm fraction was then care-
fully collected, and the samples were checked for the
nonappearance of immature spermatozoa and somatic
cells using light microscopy and Hoechst staining
(Additional file 2: Figure S3).
2-DE and gel-image analysis
To extract proteins from the spermatozoa, 50 × 106 cells
were incubated in rehydration buffer for 1 h at 4 °C [17,
18, 48]. Then, 250 μg aliquots of sperm protein were
placed in 450 μL of rehydration buffer in a rehydration
tray with 24 cm-long NL Immobiline DryStrips (pH 3–
11; Amersham, Piscataway, NJ, USA) for 12 h at 4 °C.
The first-dimension electrophoresis (1-DE) was per-
formed using an IPGphor IEF apparatus, and the strips
were focused according to previously described settings
[17, 18, 48]. After iso-electrofocusing, the strips were
equilibrated for 15 min at RT by using equilibration buf-
fer A, whereas the second equilibration was performed
using equilibration buffer B [17, 18, 48]. Afterward, 2-
DE was carried out on 12.5 % (w/v) SDS-PAGE gels with
the strips at 100 V for 1 h and then at 500 V until the
bromophenol blue front began to migrate off the gels.
The gels were silver-stained for image analysis according
to the manufacturer’s instructions (Amersham, Piscat-
away, NJ, USA). The silver-stain was used to conduct
the present study because this method is highly sensitive,
capable of detecting minimal variants of protein in the
gel, and is compatible with downstream processing, such
as mass spectrometry [18]. The gels were scanned using
a high-resolution GS-800 calibrated scanner (Bio-Rad,
Hercules, CA, USA). Detected spots were matched and
analyzed by comparing the gels from spermatozoa
treated with BPA and the control using PDQuest 8.0
software (Bio-Rad, Hercules, CA, USA). Finally, the spot
density was calculated and normalized as the ratio of the




Proteins were subjected to in-gel trypsin digestion ac-
cording to the protocol established previously [17, 18].
Excised gel spots were destained with 100 μL of de-
stain solution (30 mM potassium ferricyanide, 100 mM
sodium thiosulfate) by shaking for 5 min. Then, the gel
spots were incubated with 200 mM ammonium bicar-
bonate for 20 min. The gel pieces were dehydrated
with 100 μL of acetonitrile and dried in a vacuum cen-
trifuge. The above procedure was repeated thrice.
Then, the dried gel pieces were rehydrated with 20 μL
of 50 mM ammonium bicarbonate containing 0.2 μg of
modified trypsin for 45 min on ice. Seventy microliters
of 50 mM ammonium bicarbonate was added after re-
moval of solution. Digestion was performed overnight
at 37 °C. The peptide solution was desalted using a
C18 nano column (homemade, Waters Corp, Milford,
MA, USA).
Desalting and concentration
The custom-made chromatographic columns were used
for desalting and concentration of the peptide mixture.
A column consisting of 100–300 nL of Poros reverse
phase R2 material (PerSeptive Biosystems, Framingham,
MA, USA) was packed in a constricted GELoader tip
(Eppendorf, Hamburg, Germany). The liquid was forced
gently into the column using a 10-mL syringe. Thirty
microliters of the peptide mixture from the digestion
supernatant was diluted with 30 μL of 5 % formic acid,
loaded onto the column, and washed with 30 μL of 5 %
formic acid. Peptides were eluted with 1.5 μL of 50 %
methanol/49 % H2O/1 % formic acid directly into a
precoated borosilicate nanoelectrospray needle (New
Objective, Woburn, MA, USA) for analysis by tandem
mass spectrometry (MS/MS).
ESI-MS/MS
MS/MS of peptides generated by in-gel digestion was
performed by nano-ESI on a MicroQ-TOF III mass
spectrometer (Bruker Daltonics, Germany) at RT. A po-
tential of 1 kV was applied to the precoated borosilicate
nanoelectrospray needles (EconoTipTM, New Objective)
in the ion source and combined with a nitrogen back-
pressure of 0–5 psi to produce a stable flow rate (10–
30 nL/min). The cone voltage was 800 V. The quadru-
pole analyzer was used to select precursor ions for
fragmentation in the hexapole collision cell. Product
ions were analyzed using an orthogonal TOF analyzer,
fitted with a reflector, a micro-channel plate detector,
and a time-to-digital converter. The data were proc-
essed using a peptide sequence system.
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Database search
An MS/MS ion search was allocated as the ion search
preference in the MASCOT software (Matrix 20 Science,
Boston, MA, USA). Peptide fragment files were obtained
from the peptide peaks in ESI-MS by ESI-MS/MS. Tryp-
sin was selected as the enzyme with one potentially
missed cleavage site. ESI-QTOF was selected as the in-
strument type. The peptide fragments were searched
based on the database using the MASCOT (v2.4, Matrix
Science) and FASTA search engine, and the search was
limited to Mus musculus taxonomy in NCBInr, Uni-
protKB/TrEMBL and UniprotKB/Swissprot database.
The mass tolerance was set at ± 1 and ± 0.6 Da for the
peptides and fragments, respectively. High-scores were
defined as those above the default significance threshold
in MASCOT (p < 0.05, peptide score, >30).
Western blotting
Western blot analysis was performed as previously de-
scribed [6, 29]. The antibodies were diluted in 3 % block-
ing agent: anti-phospho-p38 MAPK Antibody (1:1000,
Cell Signaling, Danvers, MA), Anti-PI3K p85 (phosphor
Y607) antibody (1:1000, Abcam, Cambridge, UK), anti-
phospho-PKA substrate antibody (1:10,000; Cell Signaling
Technology, MA, USA), anti-phosphotyrosine antibody
(PY20, 1:2,500, Abcam), anti- GAPDH antibody (1:1000,
Abcam), anti-UQCRFS1 antibody (1:15,000, LSBio, Inc.),
anti- PRDX5 antibody (1:2000, Abcam), anti-GPX4 anti-
body (1:15,000, Abcam), anti-ACTB antibody (1:500,
Abcam), and anti-GSTM5 antibody (1:5,000, Abcam).
Anti-α-tubulin mouse antibody (1:1000, Abcam) was used
as the loading control for all western blots. The pro-
teins on the membranes were detected with by an en-
hanced chemiluminescence (ECL) technique using ECL
detection reagents.
Signaling pathways
Pathway Studio (v 9.0, Aridane Genomics, Rockville,
MD, USA) program was used to predict the signaling
pathways and biological functions of BPA-mediated dif-
ferentially expressed (>2-fold; p < 0.05) proteins accord-
ing to previously described procedure [29, 48]. Briefly,
differentially expressed proteins were entered into the
Pathway Studio in order to determine the significantly
matching pathways for each protein (p < 0.05). To fulfill
the additional objectives, groups of proteins that signifi-
cantly related to particular pathways were subject to a
MedScan Reader (v5.0) search, and their functional affili-
ation with disease processes were predicted using Pathway
Studio. The signaling pathways and biological functions
were confirmed by the PubMed Medline hyperlink that
was embedded in each node.
Statistical analysis
The data were analyzed by one-way ANOVA using
SPSS program (v. 18.0, Chicago, IL, USA), and Tukey’s
test was used to locate differences. P values of <0.05
were considered statistically significant. All data are
expressed as mean ± SEM. The probabilities of the sig-
naling pathways were determined using the Fisher’s
exact test (p < 0.05).
Additional files
Additional file 1: Table S1. Peptide sequence, matches peptides, and
searching engines of identified proteins. (PDF 99 kb)
Additional file 2: Figure S1. Validation of the 2-DE results by western
blot analysis. (A) The bars represent the densities of particular proteins
bands, such as GAPDH, UQCRFS1, PRDX5, GPX4, ACTB, and GSTM5. Data
are presented as mean ± SEM (n = 3). Values with different superscript
characters (A,B,C) indicate significant differences between the control and
treatment samples as determined by one-way ANOVA (P < 0.05). (B)
Representative western blot image of GAPDH, UQCRFS1, PRDX5, GPX4,
ACTB, and GSTM5 probed with the respective antibodies. Figure S2. Ef-
fect of BPA on tyrosine phosphorylation status of spermatozoa. (A)
Density of phosphotyrosine proteins in control and BPA-treated samples.
Data are the mean of four replicates ± SEM. Values with different upper and
lower case letters (A,B,C,a,b,c) are significantly different between control and
treatment groups by one-way ANOVA. (B) Tyrosine-phosphorylated proteins
were probed with PY 20. Lane 1: control; lane 2: 0.0001 μM BPA; lane
3: 0.01 μM BPA; lane 4: 1 μM BPA; and lane 5: 100 μM BPA. Figure S3.
Validation of separation technique of spermatozoa for proteomic
analysis. Spermatozoa examined for the non-appearance of immature
sperm cells and somatic cells using microscopy. (A) Differential
interference contrast microscopic (DIC) image of spermatozoa used for
proteomic analyses. (B) Image of hoechst staining spermatozoa. (C)
Merged image. (PDF 936 kb)
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